A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)

NCT00440544 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Safety Issues

Conditions

Tuberculosis

Interventions

BIOLOGICAL: Ag85B-ESAT6 fusion protein H1
BIOLOGICAL: Ag85B-ESAT6 fusion protein H1
BIOLOGICAL: Ag85B-ESAT6 fusion protein H1
BIOLOGICAL: Ag85B-ESAT6 fusion protein H1
BIOLOGICAL: Ag85B-ESAT6 fusion protein H1
BIOLOGICAL: Ag85B-ESAT6 fusion protein H1

Sponsor

St George's, University of London

Collaborators

[object Object]
[object Object]
[object Object]